HealthLinx Signs South Korean Distribution Deal | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – HealthLinx today said that Seoul Clinical Laboratories will distribute the firm's OvPlex diagnostic panel in South Korea.

SCL will begin distribution of the protein biomarkers-based test once it has received marketing approval from the South Korea Food and Drug Administration. HealthLinx said it is conducting a 220-patient study aimed at supporting its marketing application.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genome sequencing study of Yakutian horses, tardigrade genome, and more.

A guest post at Retraction Watch discusses what funders can do to improve research reproducibility.

Researchers report in Nature this week that farming led to genomic adaptations in humans.

The FDA argues that it needs to evaluate the safety and efficacy of laboratory-developed tests, a proposal that divides Republicans.